Aptevo Therapeutics Inc
Biotechnology
Healthcare
APVO
72.90 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.61
52 week high
16.28
high
1.73
52 week low
0.00
previous Close
1.69
P/E ratio
-0
market cap
6.64 M
div yield
0
net incoming
-6.20 M
3.18 %
net profit margin
-620400000.00 %
0.00 %
operating incoming
-6.23 M
3.92 %
net change in cash
7.27 M
210.59 %
cash on hand
9.41 M
339.93 %
top